Phosphodiesterase 5 inhibitors for the treatment of heart failure: a systematic review and meta-analysis

CONCLUSIONS: Current data suggest that PDE-5 inhibitors therapy does not improve prognosis or quality of life among HF patients. Hemodynamic and functional effects could be relevant, and more studies are necessary to define its role.PMID:38330508 | DOI:10.24875/ACM.23000209
Source: Archivos de Cardiologia de Mexico - Category: Cardiology Authors: Source Type: research